We are selling US listed Albemarle for a loss, with the position down ~19% from our entry last month, inline with our cautious near term view on Lithium stocks. ALB was held with a 4% target weighting.
MM is selling ALB US in the International Equities Portfolio, taking a loss around $US109
Add To Hit List
